Personal‑injury attorneys who want to thrive in 2025 need two things in equal measure: cutting‑edge digital visibility and a human‑centric client experience. Last week’s leading legal podcasts delivered both. Below, we recap five standout episodes—each featuring a...
As the legal landscape shifts in response to growing concerns over the birth control injection Depo-Provera, law firms are seeing a rise in claims from injured patients. Manufactured by Pfizer, Depo-Provera has been linked to severe side effects such as osteoporosis...
There’s no denying it: artificial intelligence is shaking up industries left and right, and legal intake is no exception. With podcasts like All-In declaring that AI will wipe out call centers in the next few years, it’s easy to get swept up in the idea that...
The mass tort world has just gained a significant new case. Following the September 26th U.S. Judicial Panel on Multidistrict Litigation (JPML) hearing, yesterday’s order officially confirmed the creation of a new mass tort: In re: Angiodynamics, Inc. Port Catheter...
A groundbreaking lawsuit against pharmaceutical giant Novo Nordisk has spotlighted the severe risks of its popular drug, Ozempic, used by millions for weight loss. Filed by Quintin Welsh after the tragic death of his wife, Georganne Welsh, the lawsuit alleges that...
The Latest in the Suboxone Mass Tort: Key Developments, Payout Estimates, and Emerging Investigations The Suboxone mass tort litigation continues to evolve in 2024 as the multidistrict litigation (MDL) progresses through critical stages. With Defendant Indivior's...